Selling shares @ 0.04c.5c per share would be a realistic price.Now the share price in the short term will hover in the 4’sEPR are under selling themselves.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%